No genetic bottleneck in Plasmodium falciparum wild-type pfcrt alleles reemerging in Hainan Island, China, following high-level chloroquine resistance

被引:15
作者
Chen, Nanhua [1 ]
Gao, Qi [2 ]
Wang, Shanqing [3 ]
Wang, Guangze [3 ]
Gatton, Michelle [4 ]
Cheng, Qin [1 ,4 ]
机构
[1] Australian Army Malaria Inst, Dept Drug Resistance & Diagnost, Enoggera, Qld 4051, Australia
[2] Jiangsu Inst Parasit Dis, Jiangsu, Peoples R China
[3] Hainan Prov Ctr Dis Control & Prevent, Haikou, Hainan, Peoples R China
[4] Queensland Inst Med Res, Malaria Drug Resistance & Diagnost, Brisbane, Qld 4006, Australia
关键词
D O I
10.1128/AAC.00711-07
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Chloroquine-resistant Plasmodium falciparum was highly prevalent in Hainan, China, in the 1970s. Twenty-five years after cessation of chloroquine therapy, the prevalence of P. falciparum wild-type Pfcrt alleles has risen to 36% (95% confidence interval, 22.1 to 52.4%). The diverse origins of wild-type alleles indicate that there was no genetic bottleneck caused by high chloroquine resistance.
引用
收藏
页码:345 / 347
页数:3
相关论文
共 10 条
[1]   In vitro activities of piperaquine and other 4-aminoquinolines against clinical isolates of Plasmodium falciparum in Cameroon [J].
Basco, LK ;
Ringwald, P .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (04) :1391-1394
[2]   Origin and dissemination of chloroquine-resistant Plasmodium falciparum with mutant pfcrt alleles in the Philippines [J].
Chen, NH ;
Wilson, DW ;
Pasay, C ;
Bell, D ;
Martin, LB ;
Kyle, D ;
Cheng, Q .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (05) :2102-2105
[3]   pfcrt allelic types with two novel amino acid mutations in chloroquine-resistant Plasmodium falciparum isolates from the Philippines [J].
Chen, NH ;
Kyle, DE ;
Pasay, C ;
Fowler, EV ;
Baker, J ;
Peters, JM ;
Cheng, Q .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (11) :3500-3505
[4]  
Fidock DA, 2000, MOL CELL, V6, P861, DOI 10.1016/S1097-2765(05)00077-8
[5]   Reemergence of chloroquine-sensitive Plasmodium falciparum malaria after cessation of chloroquine use in Malawi [J].
Kublin, JG ;
Cortese, JF ;
Njuniu, EM ;
Mukadam, RAG ;
Wirima, JJ ;
Kazembe, PN ;
Djimdé, AA ;
Kouriba, B ;
Taylor, TE ;
Plowe, CV .
JOURNAL OF INFECTIOUS DISEASES, 2003, 187 (12) :1870-1875
[6]  
LIU DQ, 1995, B WORLD HEALTH ORGAN, V73, P483
[7]   Molecular analysis of recrudescent parasites in a Plasmodium falciparum drug efficacy trial in Gabon [J].
Ranford-Cartwright, LC ;
Taylor, J ;
Umasunthar, T ;
Taylor, LH ;
Babiker, HA ;
Lell, B ;
Schmidt-Ott, JR ;
Lehman, LG ;
Walliker, D ;
Kremsner, PG .
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 1997, 91 (06) :719-724
[8]   Decreased prevalence of the Plasmodium falciparum chloroquine resistance transporter 76T marker associated with cessation of chloroquine use against P-falciparum malaria in Hainan, People's Republic of China [J].
Wang, XH ;
Mu, JB ;
Li, GQ ;
Chen, PQ ;
Guo, XB ;
Fu, LC ;
Chen, L ;
Su, XZ ;
Wellems, TE .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2005, 72 (04) :410-414
[9]   Chloroquine-resistant malaria [J].
Wellems, TE ;
Plowe, CV .
JOURNAL OF INFECTIOUS DISEASES, 2001, 184 (06) :770-776
[10]   Genetic diversity and chloroquine selective sweeps in Plasmodium falciparum [J].
Wootton, JC ;
Feng, XR ;
Ferdig, MT ;
Cooper, RA ;
Mu, JB ;
Baruch, DI ;
Magill, AJ ;
Su, XZ .
NATURE, 2002, 418 (6895) :320-323